Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
IGC Pharma, Inc. (IGC) had Cost of Goods Sold of $0.22M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.27M |
|
$-2.94M |
|
|
Cost of Goods Sold |
$0.22M |
$0.05M |
|
$3.05M |
|
$-2.78M |
|
$-0.15M |
|
$-2.94M |
|
$-2.94M |
|
$-2.94M |
|
$-2.94M |
|
$-2.94M |
|
$-2.94M |
|
$-2.78M |
|
$-2.73M |
|
100.33M |
|
100.33M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$1.26M |
|
$2.07M |
|
$8.23M |
|
$9.50M |
|
$3.21M |
|
$0.15M |
|
$0.15M |
|
$3.36M |
|
$6.13M |
|
$0.62M |
|
$6.13M |
|
102.42M |
|
| Cash Flow Statement Financials | |
$-2.57M |
|
$-0.42M |
|
$2.44M |
|
$0.90M |
|
$0.33M |
|
$-0.57M |
|
$1.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.39 |
|
-- |
|
-- |
|
0.02 |
|
0.18 |
|
18.11% |
|
-1050.57% |
|
-1050.57% |
|
-- |
|
-1107.92% |
|
-1107.92% |
|
$-2.58M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.34 |
|
4.73 |
|
19.02 |
|
-47.88% |
|
-469.76% |
|
-30.92% |
|
-46.74% |
|
$0.06 |
|
$-0.03 |
|
$-0.03 |
|